NCT01677962View on ClinicalTrials.gov

A Study of Vaccination With Poly-ICLC and Dendritic Cells in Patients With Pancreatic Adenocarcinoma

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

September 30, 2014

Study Completion Date

May 31, 2016

Conditions
Pancreatic Adenocarcinoma Non-resectable
Interventions
BIOLOGICAL

Poly-ICLC

BIOLOGICAL

dendritic cell

Trial Locations (1)

29425

Medical University of South Carolina, Charleston

All Listed Sponsors
lead

Medical University of South Carolina

OTHER

NCT01677962 - A Study of Vaccination With Poly-ICLC and Dendritic Cells in Patients With Pancreatic Adenocarcinoma | Biotech Hunter | Biotech Hunter